- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02594748
The Effects of Self-management Education Based on Theory of Planned Behavior on Patients With Type 2 Diabetes
October 24, 2016 updated by: FangFang Zhao, University of Turku
The Effects of Self-management Education Based on Theory of Planned Behavior on Self-management and Quality of Life of Patients With Type 2 Diabetes and the Other Influencing Factors of Quality of Life
The aims of the study are as follows:
- To improve self-management intention and behavior of patients with type 2 diabetes (T2 DM).
- To promote patients to make plans for their self-management and gradually integrate the self-management plan into their daily life.
- To improve resilience, well-being, fatigue and quality of life of patients with T2 DM
In order to achieve the aims, we have set the following objectives:
- To develop and apply self-management education program based on the extended theory of planned behavior.
To evaluate the efficacy of the educational program:
- Self-management education program delivered face to face (intervention group); (b) standard usual care (comparison group).
Study Overview
Status
Suspended
Conditions
Intervention / Treatment
Detailed Description
This study employs a quasi-experimental study design with an intervention and comparison group and follow-up of 3 months; there will be two measuring points (baseline and 3 months after the intervention) , and 9 measures.
Study Type
Interventional
Enrollment (Anticipated)
280
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Nantong, Jiangsu, China, 226001
- The First People Hospital, Affiliated hospital of Nantong University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age ≥18 years
- duration of type 2 diabetes ≥3 months
- without any severe complication and impaired cognition.
Exclusion criteria are:
- severe physical handicap or mental illness
- presence of other serious disease such as cancer and stroke.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
Intervention is administered to patients in this Arm.
The intervention is self-management education based on the theory of planned behavior(TPB).
The intervention of experimental group is individual guide and face to face education based on TPB.
|
The intervention group will receive diabetes self-management education based on the idea of extended theory of planned behavior .
|
|
Active Comparator: Comparison group
The comparison group will receive routine care
|
They will attend the routine lecture in hospital sit and listen, usually 1-2 times during one week in hospital
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in Audit of Diabetes Dependent Quality of Life at 3-month follow up.
Time Frame: baseline and at three months.
|
Measure the impact and important of 19 life domains.
|
baseline and at three months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in Fatigue-14 scale at 3-month follow up.
Time Frame: Baseline,3-month follow up.
|
Baseline,3-month follow up.
|
|
|
Change from baseline in Well-Being Index (WHO-5)
Time Frame: Baseline,3-month follow up.
|
Baseline,3-month follow up.
|
|
|
Change from baseline in The Summary of Diabetes Self-Care Activities Measure at 3-month follow up.
Time Frame: Baseline,3-month follow up.
|
The scale include diet, exercise, medication, foot care and blood sugar monitoring
|
Baseline,3-month follow up.
|
|
Change from baseline in self-management planned behavior developed according to guideline at 3-month follow up.
Time Frame: Baseline,3-month follow up.
|
It is based on theory of planned behavior according to the following guideline.
Including attitude, subjective norm, perceived behavior control, intention and behavior, action planning and coping planning.The response used likert 1-7 format.
|
Baseline,3-month follow up.
|
|
Change from baseline in Connor-Davidson Resilience Scale-10 at 3-month follow up.
Time Frame: Baseline,3-month follow up.
|
Baseline,3-month follow up.
|
|
|
Change from baseline in HbA1c at 3-month follow up.
Time Frame: Baseline, 3-month follow up.
|
HbA1c will be measured at outpatient of hospital.
|
Baseline, 3-month follow up.
|
|
Change from baseline in BMI at 3-month follow up.
Time Frame: Baseline,3-month follow up.
|
BMI will be measured at hospital and participants' home.
|
Baseline,3-month follow up.
|
|
Change from baseline in Blood sugar at 3-month follow up.
Time Frame: Baseline,3-month follow up.
|
Blood sugar will be measured at hospital and participants' home.
|
Baseline,3-month follow up.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Helena leino-kilpi, PhD, Department of Nursing Science, Universtiy of Turku
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2015
Primary Completion (Anticipated)
June 1, 2017
Study Completion (Anticipated)
December 1, 2019
Study Registration Dates
First Submitted
October 27, 2015
First Submitted That Met QC Criteria
October 31, 2015
First Posted (Estimate)
November 3, 2015
Study Record Updates
Last Update Posted (Estimate)
October 25, 2016
Last Update Submitted That Met QC Criteria
October 24, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BK2014011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
Clinical Trials on Self-management education
-
Jimma UniversityRecruitingRheumatic Diseases | Rheumatic FeverEthiopia
-
Imperial College LondonBUPA FoundationCompletedAsthmaUnited Kingdom
-
Meir Medical CenterUnknown
-
University of ArkansasPatient-Centered Outcomes Research InstituteCompletedDiabetes Mellitus, Type 2United States
-
Taipei Medical UniversityMinistry of Science and Technology, TaiwanRecruiting
-
University of MichiganActive, not recruiting
-
Lawson Health Research InstituteGlaxoSmithKline; PfizerCompleted
-
University of Sao PauloCompletedChronic Low Back PainBrazil
-
Hiroshima UniversityCompletedChronic Kidney Disease on HemodialysisCambodia
-
Wuxi No. 2 People's HospitalActive, not recruitingElderly | Education | Self-management | EnterostomyChina